Literature DB >> 3035312

Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress.

G M Gilad, J M Rabey, V H Gilad.   

Abstract

Synaptosomal preparations from rat hippocampus were incubated with methylprednisolone or adrenocorticotropin. High affinity choline uptake was not affected by either hormones. Methylprednisolone however enhanced newly synthesized acetylcholine release in the presence of high potassium or acetylcholine concentrations, while adrenocorticotropin had no effect. Dopamine uptake was inhibited when synaptosomes from septum or striatum were incubated with methylprednisolone. We conclude: a) high glucocorticoid concentrations and not adrenocorticotropin can directly enhance acetylcholine release but only from stimulated cholinergic synaptosomes, and b) high glucocorticoids can reduce dopamine uptake by dopaminergic synaptosomes. The results imply that increased glucocorticoid levels during stress or disease, can directly modulate the neuronal activity of specific cholinergic and dopaminergic systems in the brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035312     DOI: 10.1016/0024-3205(87)90754-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  On the role of glucocorticoid receptors in brain plasticity.

Authors:  K Fuxe; R Diaz; A Cintra; M Bhatnagar; B Tinner; J A Gustafsson; S O Ogren; L F Agnati
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

2.  Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission.

Authors:  P V Piazza; M Barrot; F Rougé-Pont; M Marinelli; S Maccari; D N Abrous; H Simon; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 3.  Glucocorticoids and the hippocampus. Developmental interactions facilitating the expression of behavioral inhibition.

Authors:  L K Takahashi
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

Review 4.  Individual differences and social influences on the neurobehavioral pharmacology of abused drugs.

Authors:  M T Bardo; J L Neisewander; T H Kelly
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

5.  Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission.

Authors:  P V Piazza; F Rougé-Pont; V Deroche; S Maccari; H Simon; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice.

Authors:  J R Pauly; E U Grün; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking.

Authors:  Evan N Graf; Robert A Wheeler; David A Baker; Amanda L Ebben; Jonathan E Hill; Jayme R McReynolds; Mykel A Robble; Oliver Vranjkovic; Daniel S Wheeler; John R Mantsch; Paul J Gasser
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

8.  Corticosterone down-regulates dopamine D4 receptor in a mouse cerebral cortex neuronal cell line.

Authors:  Virginia G Barros; Lorena A Boado; Ana M Adamo; Raúl Caviedes; Pablo Caviedes; Marta C Antonelli
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  A proposed role for glucocorticoids in mediating dopamine-dependent cue-reward learning.

Authors:  Sofia A Lopez; Shelly B Flagel
Journal:  Stress       Date:  2020-06-11       Impact factor: 3.493

10.  Changes in the central GABAergic system after acute treatment with corticosterone.

Authors:  M E Losada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.